Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults.
Mino M, Sano A, Kakazu E, Matsubara H, Kakisaka K, Kogure T, Sekine K, Aoki Y, Imamura M, Matsuda M, Yamazoe T, Mori T, Yoshio S, Inoue J, Masamune A, Kanto T. Mino M, et al. Among authors: aoki y. J Gastroenterol. 2024 Jun;59(6):483-493. doi: 10.1007/s00535-024-02092-0. Epub 2024 Mar 26. J Gastroenterol. 2024. PMID: 38530472
LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
Ito K, Kuno A, Ikehara Y, Sugiyama M, Saito H, Aoki Y, Matsui T, Imamura M, Korenaga M, Murata K, Masaki N, Tanaka Y, Hige S, Izumi N, Kurosaki M, Nishiguchi S, Sakamoto M, Kage M, Narimatsu H, Mizokami M. Ito K, et al. Among authors: aoki y. Hepatology. 2012 Oct;56(4):1448-56. doi: 10.1002/hep.25815. Hepatology. 2012. PMID: 22535703
Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients.
Saito H, Ito K, Sugiyama M, Matsui T, Aoki Y, Imamura M, Murata K, Masaki N, Nomura H, Adachi H, Hige S, Enomoto N, Sakamoto N, Kurosaki M, Mizokami M, Watanabe S. Saito H, et al. Among authors: aoki y. Hepatol Res. 2012 Oct;42(10):958-65. doi: 10.1111/j.1872-034X.2012.01013.x. Epub 2012 Apr 26. Hepatol Res. 2012. PMID: 22536875
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.
Murata K, Sugiyama M, Kimura T, Yoshio S, Kanto T, Kirikae I, Saito H, Aoki Y, Hiramine S, Matsui T, Ito K, Korenaga M, Imamura M, Masaki N, Mizokami M. Murata K, et al. Among authors: aoki y. J Gastroenterol. 2014 Jan;49(1):126-37. doi: 10.1007/s00535-013-0814-1. Epub 2013 Apr 17. J Gastroenterol. 2014. PMID: 23591768 Free PMC article.
Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection.
Aoki Y, Sugiyama M, Murata K, Yoshio S, Kurosaki M, Hashimoto S, Yatsuhashi H, Nomura H, Kang JH, Takeda T, Naito S, Kimura T, Yamagiwa Y, Korenaga M, Imamura M, Masaki N, Izumi N, Kage M, Mizokami M, Kanto T. Aoki Y, et al. J Gastroenterol. 2015 Aug;50(8):894-902. doi: 10.1007/s00535-014-1023-2. Epub 2014 Dec 14. J Gastroenterol. 2015. PMID: 25501286
Scirrhous colonic metastasis from lobular carcinoma of breast.
Takeda T, Murata K, Chatani N, Aoki Y, Yada T, Aoki Y, Koizuka H, Korenaga M, Imamura M, Kanto T, Masaki N, Ishida T, Watanabe S, Mizokami M, Uemura N. Takeda T, et al. Among authors: aoki y. Clin J Gastroenterol. 2013 Aug;6(4):291-4. doi: 10.1007/s12328-013-0399-5. Epub 2013 Jul 3. Clin J Gastroenterol. 2013. PMID: 26181732
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.
Ueyama M, Nishida N, Korenaga M, Korenaga K, Kumagai E, Yanai H, Adachi H, Katsuyama H, Moriyama S, Hamasaki H, Sako A, Sugiyama M, Aoki Y, Imamura M, Murata K, Masaki N, Kawaguchi T, Torimura T, Hyogo H, Aikata H, Ito K, Sumida Y, Kanazawa A, Watada H, Okamoto K, Honda K, Kon K, Kanto T, Mizokami M, Watanabe S. Ueyama M, et al. Among authors: aoki y. J Gastroenterol. 2016 Apr;51(4):370-9. doi: 10.1007/s00535-015-1116-6. Epub 2015 Sep 3. J Gastroenterol. 2016. PMID: 26337813
Pro-angiogenic TIE-2-expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma.
Shoji H, Yoshio S, Mano Y, Doi H, Sugiyama M, Osawa Y, Kimura K, Arai T, Itokawa N, Atsukawa M, Aoki Y, Fukai M, Taketomi A, Mizokami M, Kanto T. Shoji H, et al. Among authors: aoki y. Int J Cancer. 2017 Sep 1;141(5):1011-1017. doi: 10.1002/ijc.30804. Epub 2017 Jun 8. Int J Cancer. 2017. PMID: 28555943 Free article. Clinical Trial.
Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
Mano Y, Yoshio S, Shoji H, Tomonari S, Aoki Y, Aoyanagi N, Okamoto T, Matsuura Y, Osawa Y, Kimura K, Yugawa K, Wang H, Oda Y, Yoshizumi T, Maehara Y, Kanto T. Mano Y, et al. Among authors: aoki y. J Gastroenterol. 2019 Nov;54(11):1007-1018. doi: 10.1007/s00535-019-01579-5. Epub 2019 Apr 2. J Gastroenterol. 2019. PMID: 30941514
3,465 results